Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Lannett Company, Inc.    LCI

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and distributes generic prescription pharmaceutical products

Lannett Co., Inc. develops, manufactures, markets and distributes generic versions of pharmaceutical products.

The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations.

Lannett was founded in 1942 and is headquartered in Philadelphia, PA.
Managers
NameAgeSinceTitle
Arthur P. Bedrosian702000Chief Executive Officer & Director
Jeffrey Farber562003Chairman
Martin P. Galvan, CPA642011CFO, Treasurer & Vice President-Finance
Robert Ehlinger592006Chief Information Officer & VP-logistics
Mahendra Dedhiya PhD, MBA672015Vice President-Scientific Affairs
David A. Drabik482010Lead Independent Director
Paul Taveira562012Independent Director
James M. Maher632013Independent Director
Albert R. Paonessa III562015Independent Director
Kevin R. Smith562002Senior Vice President-Sales & Marketing
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 37,290,257 27,445,327 73.6% 542,756 1.5% 73.6%
Shareholders
NameEquities%
Jeffrey Farber 4,687,420 12.8%
Telemus Capital LLC 4,612,073 12.6%
BlackRock Fund Advisors 2,666,603 7.26%
Invesco PowerShares Capital Management LLC 1,936,843 5.27%
David Farber 1,876,313 5.11%
The Vanguard Group, Inc. 1,825,358 4.97%
Coatue Management LLC 1,805,431 4.91%
SSgA Funds Management, Inc. 1,207,793 3.29%
Thompson, Siegel & Walmsley LLC 1,099,825 2.99%
Dimensional Fund Advisors LP 879,124 2.39%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
LANNETT COMPANY, INC.1 127
JOHNSON & JOHNSON21.72%343 913
PFIZER INC.13.82%222 823
NOVARTIS AG-5.53%219 526
ROCHE HOLDING LTD.-9.55%218 832
MERCK & CO., INC.11.36%162 815
BRISTOL-MYERS SQUIBB C..10.02%126 333
NOVO NORDISK A/S-5.44%111 381
SANOFI-3.03%108 205
GLAXOSMITHKLINE PLC20.87%105 959
ALLERGAN PLC-20.33%98 486
ELI LILLY AND CO-3.17%90 116
BAYER AG-20.73%83 560
ASTRAZENECA PLC-2.01%77 183
ABBOTT LABORATORIES-3.87%63 423
SHIRE PLC4.60%58 447
TEVA PHARMACEUTICAL IN..-16.35%50 478
ASTELLAS PHARMA INC-3.61%33 577
TAKEDA PHARMACEUTICAL ..-25.70%33 169
MYLAN NV-13.83%23 685
CHUGAI PHARMACEUTICAL ..-6.47%20 549
Sector Pharmaceuticals - NEC
Lannett Company, Inc. : Connections
Cranbrook & Co. Llc
Generic Pharmaceutical Co.
Auburn Pharmaceuticals, Inc.
Grason-Stadler, Inc.
National Response Corp.
The American Institute of Certified Public Accountants
Healthcare Distribution Management Association
Company contact information
Lannett Co., Inc.
13200 Townsend Road
Philadelphia, PA 19154

Phone : +1.215.333.9000
Fax : +1.215.333.9004
Web : www.lannett.com
© 2016 People , Fundamentals and Ownership